Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-050555
Filing Date
2012-09-14
Accepted
2012-09-14 16:19:31
Documents
1
Period of Report
2012-09-14

Document Format Files

Seq Description Document Type Size
1 LEW OPTION EXERCISE rrd356179.html 4  
1 LEW OPTION EXERCISE rrd356179.xml 4 6500
  Complete submission text file 0001181431-12-050555.txt   7862
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2929 SEVENTH STREET, SUITE 100 BERKELEY CA 94710
Business Address
Lew Jennifer (Reporting) CIK: 0001465994 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34207 | Film No.: 121092851